Search

Your search keyword '"van Pampus MG"' showing total 9 results
Start Over Author "van Pampus MG" Publication Type Electronic Resources

Refine your results

9 results on '"van Pampus MG"'

1. Development and Measurement of Guidelines-Based Quality Indicators of Caesarean Section Care in the Netherlands: A RAND-Modified Delphi Procedure and Retrospective Medical Chart Review

Author

Melman, S, Schoorel, ECN, de Boer, K, Burggraaf, H, Derks, JB, van Dijk, D, van Dillen, J, Dirksen, CD, Duvekot, J.J., Franx, A, Hasaart, THM, Huisjes, AJM, Kolkman, D, van Kuijk, S, Kwee, A, Mol, BW, van Pampus, MG, de Roon-Immerzeel, A, van Roosmalen, JJM, Roumen, FJME, Smid-Koopman, E, Smits, L, Spaans, WA, Visser, H, van Wijngaarden, WJ, Willekes, C, Wouters, MGAJ, Nijhuis, JG, Hermens, RPMG, Scheepers, HCJ, Melman, S, Schoorel, ECN, de Boer, K, Burggraaf, H, Derks, JB, van Dijk, D, van Dillen, J, Dirksen, CD, Duvekot, J.J., Franx, A, Hasaart, THM, Huisjes, AJM, Kolkman, D, van Kuijk, S, Kwee, A, Mol, BW, van Pampus, MG, de Roon-Immerzeel, A, van Roosmalen, JJM, Roumen, FJME, Smid-Koopman, E, Smits, L, Spaans, WA, Visser, H, van Wijngaarden, WJ, Willekes, C, Wouters, MGAJ, Nijhuis, JG, Hermens, RPMG, and Scheepers, HCJ

Abstract

Background There is an ongoing discussion on the rising CS rate worldwide. Suboptimal guideline adherence may be an important contributor to this rise. Before improvement of care can be established, optimal CS care in different settings has to be defined. This study aimed to develop and measure quality indicators to determine guideline adherence and identify target groups for improvement of care with direct effect on caesarean section (CS) rates. Method Eighteen obstetricians and midwives participated in an expert panel for systematic CS quality indicator development according to the RAND-modified Delphi method. A multi-center study was performed and medical charts of 1024 women with a CS and a stratified and weighted randomly selected group of 1036 women with a vaginal delivery were analysed. Quality indicator frequency and adherence were scored in 2060 women with a CS or vaginal delivery. Results The expert panel developed 16 indicators on planned CS and 11 indicators on unplanned CS. Indicator adherence was calculated, defined as the number of women in a specific obstetrical situation in which care was performed as recommended in both planned and unplanned CS settings. The most frequently occurring obstetrical situations with low indicator adherence were: 1) suspected fetal distress (frequency 17%, adherence 46%), 2) nonprogressive labour (frequency 12%, CS performed too early in over 75%), 3) continuous support during labour (frequency 88%, adherence 37%) and 4) previous CS (frequency 12%), with adequate counselling in 15%. Conclusions We identified four concrete target groups for improvement of obstetrical care, which can be used as a starting point to reduce CS rates worldwide.

Published
2016

2. Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications

Author

Rodger, M, Carrier, M, Le Gal, G, Martinelli, I, Perna, A, Rey, E, de Vries, J, Gris, J, Chauleur, C, Molinari, N, Mares, P, Fabbro Peray, P, Quere, I, Lefrant, J, Haddad, B, Dauzat, M, van Pampus, M, Hague, W, Bezemerand, P, Joosten, J, Ruggenenti, P, Cetin, I, Pardi, G, Vergani, P, Acaia, B, Facchinetti, F, Sala, G, Bozzo, M, Rampello, S, Marozio, L, Diadei, O, Gherardi, G, Carminati, S, Remuzzi, G, Mannucci, P, Garneau, P, David, M, Gauthier, R, Leduc, L, Michon, N, Morin, F, Demers, C, Kahn, S, Magee, L, Rodger, MA, de Vries, JI, Gris, JC, Lefrant, JY, van Pampus, MG, Hague, WM, Bezemerand, PD, Joosten, JH, Mannucci, PM, Kahn, SR, Magee, LA, VERGANI, PATRIZIA, Rodger, M, Carrier, M, Le Gal, G, Martinelli, I, Perna, A, Rey, E, de Vries, J, Gris, J, Chauleur, C, Molinari, N, Mares, P, Fabbro Peray, P, Quere, I, Lefrant, J, Haddad, B, Dauzat, M, van Pampus, M, Hague, W, Bezemerand, P, Joosten, J, Ruggenenti, P, Cetin, I, Pardi, G, Vergani, P, Acaia, B, Facchinetti, F, Sala, G, Bozzo, M, Rampello, S, Marozio, L, Diadei, O, Gherardi, G, Carminati, S, Remuzzi, G, Mannucci, P, Garneau, P, David, M, Gauthier, R, Leduc, L, Michon, N, Morin, F, Demers, C, Kahn, S, Magee, L, Rodger, MA, de Vries, JI, Gris, JC, Lefrant, JY, van Pampus, MG, Hague, WM, Bezemerand, PD, Joosten, JH, Mannucci, PM, Kahn, SR, Magee, LA, and VERGANI, PATRIZIA

Abstract

A 35-year-old woman with recurrent severe placenta-mediated pregnancy complications in her 2 pregnancies asks: Will low-molecular-weight heparin help prevent recurrent placenta-mediated pregnancy complications in my next pregnancy? We performed a meta-analysis of randomized controlled trials (RCTs) comparing low-molecular-weight heparin (LMWH) vs no LMWH for the prevention of recurrent placenta-mediated pregnancy complications. We identified six RCTs that included a total of 848 pregnant women with prior placenta-mediated pregnancy complications. The primary outcome was a composite of pre-eclampsia (PE), birth of a small-for-gestational-age (SGA) newborn (<10th percentile), placental abruption, or pregnancy loss >20 weeks. Overall, 67 (18.7%) of 358 of women being given prophylactic LMWH had recurrent severe placenta-mediated pregnancy complications compared with 127 (42.9%) of 296 women with no LMWH (relative risk reduction, 0.52; 95% CI, 0.32 to 0.86; P = .01; I-2, 69%, indicating moderate heterogeneity). We identified similar relative risk reductions with LMWH for individual outcomes, including any PE, severe PE, SGA <10th percentile, SGA <5th percentile, preterm delivery <37 weeks, and preterm delivery <34 weeks with minimal heterogeneity. LMWH may be a promising therapy for recurrent, especially severe, placenta-mediated pregnancy complications, but further research is required

Published
2014

3. Pessaries in multiple pregnancy as a prevention of preterm birth: the ProTwin Trial (vol 9, 44, 2009)

Author

Liem, SMS, Bekedam, DJ, Bloemenkamp, KWM, Kwee, A, Papatsonis, Dimitri, van der Post, JAM, Lim, AC, Scheepers, HCJ, Willekes, C, Duvekot, J.J., Spaanderman, M, Porath, M, van Eyck, J, Haak, MC, van Pampus, MG, Bruinse, HW, Mol, BWJ (Ben), Hegeman, MA, Liem, SMS, Bekedam, DJ, Bloemenkamp, KWM, Kwee, A, Papatsonis, Dimitri, van der Post, JAM, Lim, AC, Scheepers, HCJ, Willekes, C, Duvekot, J.J., Spaanderman, M, Porath, M, van Eyck, J, Haak, MC, van Pampus, MG, Bruinse, HW, Mol, BWJ (Ben), and Hegeman, MA

Published
2012

4. Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCT

Author

Boers, KE, van Wyk, L, van der Post, JAM, Kwee, A, van Pampus, MG, Spaanderdam, MEA, Duvekot, J.J., Bremer, HA, Delemarre, FMC, Bloemenkamp, KWM, de Groot, CJM, Willekes, C, Rijken, Mikel, Roumen, FJME, Thornton, JG, van Lith, JMM, Mol, BWJ (Ben), le Cessie, S, Scherjon, SA, Boers, KE, van Wyk, L, van der Post, JAM, Kwee, A, van Pampus, MG, Spaanderdam, MEA, Duvekot, J.J., Bremer, HA, Delemarre, FMC, Bloemenkamp, KWM, de Groot, CJM, Willekes, C, Rijken, Mikel, Roumen, FJME, Thornton, JG, van Lith, JMM, Mol, BWJ (Ben), le Cessie, S, and Scherjon, SA

Abstract

OBJECTIVE: The Disproportionate Intrauterine Growth Intervention Trial at Term (DIGITAT) compared induction of labor and expectant management in suspected intrauterine growth restriction (IUGR) at term. In this subanalysis, we report neonatal morbidity between the policies based on the Morbidity Assessment Index for Newborns (MAIN). STUDY DESIGN: We used data from the DIGITAT. For each neonate, we calculated the MAIN score, a validated outcome scale. RESULTS: There were no differences in mean MAIN scores or in MAIN morbidity categories. We found that neonatal admissions are lower after 38 weeks' gestational age compared with 36 and 37 weeks in both groups. CONCLUSION: The incidence of neonatal morbidity in IUGR at term is comparable and relatively mild either after induction or after an expectant policy. However, neonatal admissions are lower after 38 weeks of pregnancy, so if induction to preempt possible stillbirth is considered, it is reasonable to delay until 38 weeks, provided watchful monitoring.

Published
2012

5. IMproving PArticipation of patients in Clinical Trials - rationale and design of IMPACT

Author

Oude Rengerink, K, Opmeer, BC, Logtenberg, SL, Hooft, L, Bloemenkamp, KWM, Haak, MC, Oudijk, MA, Spaanderman, M, Duvekot, J.J., Willekes, C, van Pampus, MG, Porath, MM, van Eyck, J, Sikkema, MJ, Mol, BWJ (Ben), Oude Rengerink, K, Opmeer, BC, Logtenberg, SL, Hooft, L, Bloemenkamp, KWM, Haak, MC, Oudijk, MA, Spaanderman, M, Duvekot, J.J., Willekes, C, van Pampus, MG, Porath, MM, van Eyck, J, Sikkema, MJ, and Mol, BWJ (Ben)

Published
2010

6. Pessaries in multiple pregnancy as a prevention of preterm birth: the ProTwin Trial

Author

Hegeman, MA, Bekedam, DJ, Bloemenkamp, KWM, Kwee, A, Papatsonis, Dimitri, Van der Post, JAM, Lim, AC, Scheepers, HCJ, Willekes, C, Duvekot, J.J., Spaanderman, M, Porath, MM, van Eyck, J, Haak, MC, van Pampus, MG, Bruinse, HW, Mol, BWJ (Ben), Hegeman, MA, Bekedam, DJ, Bloemenkamp, KWM, Kwee, A, Papatsonis, Dimitri, Van der Post, JAM, Lim, AC, Scheepers, HCJ, Willekes, C, Duvekot, J.J., Spaanderman, M, Porath, MM, van Eyck, J, Haak, MC, van Pampus, MG, Bruinse, HW, and Mol, BWJ (Ben)

Published
2009

7. Assessment of perinatal outcome after sustained tocolysis in early labour( APOSTEL-II trial)

Author

Roos, C (Carolien), Scheepers, LH, Bloemenkamp, KWM, Bolte, AC, Cornette, JMJ, Derks, JB, Duvekot, JJ, van Eyck, J, Kok, JH, Kwee, A, Meriën, Tony, Opmeer, BC, van Pampus, MG, Papatsonis, Dimitri, Porath, MM, Van der Post, JAM, Scherjon, SA, Sollie, KM, Spaanderman, M, Vijgen, SM, Willekes, C, Mol, BWJ (Ben), Lotgering, FK (Fred), Roos, C (Carolien), Scheepers, LH, Bloemenkamp, KWM, Bolte, AC, Cornette, JMJ, Derks, JB, Duvekot, JJ, van Eyck, J, Kok, JH, Kwee, A, Meriën, Tony, Opmeer, BC, van Pampus, MG, Papatsonis, Dimitri, Porath, MM, Van der Post, JAM, Scherjon, SA, Sollie, KM, Spaanderman, M, Vijgen, SM, Willekes, C, Mol, BWJ (Ben), and Lotgering, FK (Fred)

Published
2009

8. Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial)

Author

Vis, JY, Wilms, FF, Oudijk, MA, Porath, MM, Scheepers, HC, Bloemenkamp, KWM, Bolte, AC, Cornette, JMJ, Derks, JB, Duvekot, JJ, van Eyck, J, Kwee, A, Opmeer, BC, van Pampus, MG, Lotgering, FK (Fred), Scherjon, SA, Sollie, KM, Spaanderman, M, Willekes, C, Van der Post, JAM, Mol, BWJ (Ben), Vis, JY, Wilms, FF, Oudijk, MA, Porath, MM, Scheepers, HC, Bloemenkamp, KWM, Bolte, AC, Cornette, JMJ, Derks, JB, Duvekot, JJ, van Eyck, J, Kwee, A, Opmeer, BC, van Pampus, MG, Lotgering, FK (Fred), Scherjon, SA, Sollie, KM, Spaanderman, M, Willekes, C, Van der Post, JAM, and Mol, BWJ (Ben)

Published
2009

9. Disproportionate intrauterine growth intervention trial at term: DIGITAT

Author

Boers, KE, Bijlenga, D, Mol, BWJ (Ben), le Cessie, S, Birnie, Erwin, van Pampus, MG, Stigter, RH, Bloemenkamp, KWM, van Meir, CA, Van der Post, JAM, Bekedam, DJ, Ribbert, LSM, Drogtrop, AP, van der Salm, PCM, Huisjes, AJM, Willekes, C, Roumen, FJME, Scheepers, HCJ, de Boer, K, Duvekot, JJ, Thornton, JG, Scherjon, SA, Boers, KE, Bijlenga, D, Mol, BWJ (Ben), le Cessie, S, Birnie, Erwin, van Pampus, MG, Stigter, RH, Bloemenkamp, KWM, van Meir, CA, Van der Post, JAM, Bekedam, DJ, Ribbert, LSM, Drogtrop, AP, van der Salm, PCM, Huisjes, AJM, Willekes, C, Roumen, FJME, Scheepers, HCJ, de Boer, K, Duvekot, JJ, Thornton, JG, and Scherjon, SA

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results